Tenet Healthcare

Tenet Healthcare Corp. engages in the provision of health care services. It operates through the following segments: Hospital Operations and Other, Ambulatory Care, and Conifer. The Hospital Operations and Other segment consists of acute care hospitals, ancillary outpatient facilities, urgent care centers, microhospitals and physician practices. The Ambulatory Care segment includes the operations of the USPI joint venture and the company's nine Aspen facilities in the United Kingdom. The Conifer segment offers healthcare business process services in the areas of hospital and physician revenue cycle management and value-based care solutions to healthcare systems, as well as individual hospitals, physician practices, self-insured organizations, health plans and other entities. The company was founded in 1975 and is headquartered in Dallas, TX.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Tenet Healthcare reports robust Q4 earnings, eyes growth opportunities

Tenet Healthcare's Q4 2022 performance showcased strong financial results, effective cash flow management, and positive growth projections for 2023.
While facing challenges such as cyber attacks and COVID-related disruptions, the company is focused on addressing contract labor costs and driving growth.
Opportunities for Tenet Healthcare include organic growth, strategic acquisitions, and enhancing operational efficiencies to drive future success.
Overall, Tenet Healthcare's performance, strengths, challenges, and opportunities position the company for continued growth and financial stability.

Tenet Healthcare excels in Q1 2023, eyes growth opportunities

Tenet Healthcare's Q1 2023 performance was robust, driven by strong results in USPI and the hospital segment.
Challenges include deferred procedures in certain healthcare services and managing labor shortages, but opportunities exist in ortho procedure growth and improved contract labor rates.
The company's focus on efficiency and partnership benefits bode well for future growth and margin improvement.

Tenet Healthcare reports robust Q2 earnings, raises full-year guidance

Tenet Healthcare's Q2 2023 performance reflects strong financial results across segments, with raised EBITDA guidance and solid cash flow generation.
While facing challenges in specific markets and increased CapEx, the company remains focused on sustaining profitability and enhancing shareholder value.
Opportunities lie in continued growth prospects, strategic investments, and operational improvements to drive long-term success and market expansion.
Overall, Tenet Healthcare's performance highlights resilience, strategic focus, and commitment to delivering value to shareholders amidst evolving market dynamics.

Tenet Healthcare excels in Q3, eyes growth in USPI specialties

Tenet Healthcare's Q3 2023 performance showcased strong financial results across its segments, with a focus on high acuity services and cost control.
While facing challenges such as rising medical fee costs and clinical denials, Tenet is strategically positioned to capitalize on growth opportunities in USPI specialties and margin expansion.
The company's emphasis on technology investments, labor optimization, and strategic decision-making underscores its commitment to sustainable growth and operational efficiency.
With an upwardly revised guidance for 2023 and plans for 2024 formulation, Tenet Healthcare is poised for continued success through prudent financial management and strategic initiatives.

Tenet Healthcare posts robust Q4 earnings, eyes growth opportunities

Tenet Healthcare delivered strong financial results in Q4 2023, with solid EBITDA figures across its segments and a positive outlook for 2024. While facing challenges such as regulatory impacts and labor management, the company remains focused on capital allocation priorities and growth opportunities in high acuity services and ASC diversification.

Tenet Healthcare excels in Q1 2024, eyes growth opportunities

Tenet Healthcare's Q1 2024 performance showcased strong financial results, with notable growth in adjusted EBITDA across segments and successful deleveraging.
The company's strategic initiatives, including divestitures, acquisitions, and focus on revenue optimization, position it well for future growth and profitability.
Despite challenges like margin dilution from recent acquisitions and calendar effects, Tenet's focus on enhancing operational efficiency and seizing growth opportunities remains key.

Tenet Healthcare excels in Q2, eyes growth through efficiency

Tenet Healthcare's Q2 2024 earnings call reflects strong financial performance, strategic initiatives, and a positive outlook for the full year, underpinned by revenue growth and operational enhancements.
While facing challenges in margin management and revenue mix sustainability, Tenet's focus on efficiency, debt reduction, and shareholder value creation positions it well for future growth.
The company's emphasis on operational efficiency, capacity utilization, and strategic investments underscores its commitment to delivering quality care, driving performance, and seizing growth opportunities.

Tenet Healthcare excels in Q3, eyes strategic growth opportunities

Tenet Healthcare's Q3 2024 performance reflects robust revenue growth, margin expansion, and increased guidance, underpinned by strong cash generation and strategic financial management.
While facing challenges in forecasting and capital allocation, Tenet's focus on operational efficiency and shareholder value creation positions it well for future growth and resilience.
By capitalizing on opportunities for strategic investments, debt optimization, and prudent capital deployment, Tenet can navigate industry complexities and drive sustainable value creation.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Tenet Healthcare Corp. engages in the provision of healthcare services. It operates through the Hospital Operations and Other, and Ambulatory Care segments. The Hospital Operations and Other segment is composed of acute care hospitals, ancillary outpatient facilities, urgent care centers, micro hospitals and physician practices. The Ambulatory Care segment includes the operations of the USPI joint venture and the company's nine Aspen facilities in the United Kingdom. The company was founded in 1969 and is headquartered in Dallas, TX.

Tenet (THC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Earnings Preview: Tenet Healthcare (THC) Q2 Earnings Expected to Decline

DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (NYSE: THC) plans to report results for its second quarter ending June 30, 2022, after the market closes on Thursday, July 21, 2022. The company will host a related conference call the following morning, Friday, July 22, 2022, at 10:00 a.m. Eastern time (9:00 a.m. Central time). A live webcast and audio archive of the call may be accessed through the investor relations section of Tenet's website at www.tenethealth.com/investors. About Tenet

Tenet to Report its Second Quarter 2022 Results on July 21st

Tenet Healthcare's (THC) unit, USPI, signs a joint venture partnership with UUG to acquire ownership interests in the latter's 22 ambulatory surgery centers and concurrently assuring to develop these centers.

Tenet Healthcare (THC) Unit Ties Up to Boost Urology Services

Hanesbrands

Hewlett Packard

Coca-Cola

NRG Energy

QUALCOMM

6 high-quality stocks that should be able to endure and last during a recession, as there is high demand for their products and/or services. The post 6 High-Quality Stocks to Buy to Ride Out Any Recession appeared first on InvestorPlace.

6 High-Quality Stocks to Buy to Ride Out Any Recession

DALLAS & OWINGS MILLS, Md.--(BUSINESS WIRE)--United Surgical Partners International (USPI), the largest ambulatory platform in the country and a subsidiary of Tenet Healthcare (NYSE: THC), and United Urology Group (UUG), one of the nation's largest networks of urology affiliate practices, today signed a definitive agreement to form a joint venture partnership in 22 ambulatory surgery centers (ASCs). USPI will acquire a portion of UUG's ownership interests in well-established and brand-new facil

USPI and United Urology Group to Form Joint Venture

Apollo Global Management

DraftKings

Patria Investments

Uber

Codere Online Luxembourg SA

Cohn Robbins Holdings Corp.

Expedia

Madison Square Garden Sports

Vivid Seats

After 13 years, Tiger Legatus will officially shut down. The fund owns 12 names in its portfolio, including UBER and DKNG stocks.

Hedge Fund Tiger Legatus Is Shutting Down. It Was Betting Big on These 10 Stocks.

DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (NYSE: THC) is scheduled to present at the Goldman Sachs 43rd Annual Global Healthcare Conference in Rancho Palos Verdes, CA on Tuesday, June 14, 2022, beginning at 1:00 p.m. Eastern time (10:00 a.m. Pacific time). A live webcast and audio archive of the event may be accessed through the investor relations section of Tenet's website at www.tenethealth.com/investors. The replay will be available for 30 days. About Tenet Healthcare Tenet Healt

Tenet to Participate in the Goldman Sachs 43rd Annual Global Healthcare Conference

Tenet Healthcare has held up well even as the broader market fell by quite a bit in recent months. This comes in spite of mixed, but generally favorable, financial results and mixed guidance.

Tenet Healthcare: Still A Great Healthcare Prospect At This Time

DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (NYSE: THC) today called for the redemption of all of the $1.748 billion aggregate principal amount outstanding of its 6.750% senior notes due June 15, 2023 (the “Notes”), which were issued pursuant to the Indenture, dated as of June 16, 2015, among THC Escrow Corporation II and The Bank of New York Mellon Trust Company, N.A. (the “Trustee”), as supplemented by the Supplemental Indenture thereto, dated as of June 16, 2015, among Tenet and th

Tenet Calls for Full Redemption of 6.750% Senior Notes due 2023

DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (NYSE: THC) today announced the pricing of the previously announced private placement offering and has agreed to issue and sell $2.000 billion in aggregate principal amount of senior secured first lien notes due on June 15, 2030, which will bear interest at a rate of 6.125% per annum (the “notes”). The aggregate principal amount of notes to be issued in the offering was increased to $2.000 billion from the previously announced amount of $1.8

Tenet Announces Upsizing and Pricing of its $2.000 Billion Private Offering of Senior Secured Notes

DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (NYSE: THC) today announced a private placement offering of $1.800 billion in aggregate principal amount of new senior secured first lien notes maturing in 2030 (the “notes”). Completion of the notes offering is subject to, among other things, pricing and customary closing conditions. Tenet intends to use the net proceeds from the sale of the notes, after payment of fees and expenses, to finance, together with cash on hand, the redemption of

Tenet Announces $1.800 Billion Private Offering of Senior Secured Notes

Tenet Healthcare's (THC) unit Conifer inks an agreement with Brookwood Baptist Health to deliver enhanced revenue cycle services to four of the remaining hospitals of the latter across Central Alabama.

Tenet Healthcare (THC) Unit Conifer Offers Services to Brookwood

Tenet (THC) reported earnings 30 days ago. What's next for the stock?

Why Is Tenet (THC) Down 26.4% Since Last Earnings Report?

iShares Russell 2000 ETF

Palantir Technologies

PayPal

Roku

Direxion Daily Small Cap Bull 3x Shares

Upstart Holdings

Wall Street has punished these companies and funds excessively this year, so we are sharing these undervalued stocks to catch near 2020 lows. The post 7 Undervalued Stocks to Buy Before Investors Catch On appeared first on InvestorPlace.

7 Undervalued Stocks to Buy Before Investors Catch On

DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (NYSE: THC) is scheduled to present at the Barclays High Yield Bond & Syndicated Loan Conference on Wednesday, May 25, 2022, beginning at 10:30 a.m. Eastern time (9:30 a.m. Central time). A live webcast and audio archive of the event may be accessed through the investor relations section of Tenet's website at www.tenethealth.com/investors. The replay will be available for 30 days. About Tenet Healthcare Tenet Healthcare Corporation (NYSE

Tenet to Participate in the Barclays High Yield Bond & Syndicated Loan Conference

DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (NYSE: THC) is scheduled to present at the BofA Securities 2022 Healthcare Conference in Las Vegas, NV, on Tuesday, May 10, 2022, beginning at 1:40 p.m. Eastern time (10:40 a.m. Pacific time). A live webcast and audio archive of the event may be accessed through the investor relations section of Tenet's website at www.tenethealth.com/investors. The replay will be available for 30 days. About Tenet Healthcare Tenet Healthcare Corporation (NYS

Tenet to Participate in BofA Securities 2022 Healthcare Conference

DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (NYSE: THC) experienced a cybersecurity incident last week. The Company immediately suspended user access to impacted information technology applications, executed extensive cybersecurity protection protocols, and quickly took steps to restrict further unauthorized activity. Efforts to restore impacted information technology operations continue to make important progress. While there was temporary disruption to a subset of acute care operati

Tenet Reports Cybersecurity Incident

RBC Capital Markets views Tenet Healthcare Corp's (NYSE: THC) Q1 earnings in-line with expectations reflecting solid execution and labor cost management amid January omicron headwinds.  The analysts have raised the price target from $89 to $104 (41% upside) with.

Why This Analyst Thinks Tenet Healthcare's 'Q1 In Line On Solid Execution'

Tenet Healthcare (THC) Q1 earnings gain from a healthy revenue stream, reduced expenses and operational efficiency.

Tenet Healthcare (THC) Q1 Earnings Beat Mark, Surge Y/Y

Tenet Healthcare Corporation (NYSE:THC ) Q1 2022 Earnings Conference Call April 21, 2022 10:00 AM ET Company Participants Will McDowell - IR Dan Cancelmi - EVP & CFO Ron Rittenmeyer - Executive Chairman Saum Sutaria - CEO Conference Call Participants Josh Raskin - Nephron Research Justin Lake - Wolfe Research A.J. Rice - Credit Suisse Jamie Perse - Goldman Sachs Pito Chickering - Deutsche Bank Kevin Fischbeck - Bank of America Jason Cassorla - Citi Whit Mayo - SVB Leerink John Ransom - Raymond James Brian Tanquilut - Jefferies Stephen Baxter - Wells Fargo Ben Hendrix - RBC Capital Markets Sarah James - Barclays Andrew Mok - UBS Operator Greetings and welcome to Tenet Healthcare Corporation First Quarter 2022 Earnings Conference Call.

Tenet Healthcare Corporation (THC) CEO Saum Sutaria on Q1 2022 Results - Earnings Call Transcript

Tenet (THC) delivered earnings and revenue surprises of 85.58% and 1.48%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Tenet Healthcare (THC) Tops Q1 Earnings and Revenue Estimates

DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (Tenet) (NYSE: THC) today announced its results for the quarter ended March 31, 2022 (Q1'22). Tenet's results for Q1'22 versus the quarter ended March 31, 2021 (Q1'21) follow: ($ in millions, except per share results) Q1'22 Q1'21 Net income available to Tenet common shareholders from continuing operations $139 $97 Net income available to Tenet common shareholders from continuing operations per diluted share $1.27 $0.90 Adjusted EBITDA exclud

Tenet Reports First Quarter 2022 Results; Retired over $800 Million of Debt to Date in 2022; Maintains 2022 Adjusted EBITDA Outlook

Tenet Healthcare's (THC) first-quarter 2022 results are likely to reflect an improvement in adjusted admissions and outpatient admissions.

Can Tenet Healthcare (THC) Post Q1 Earnings Beat on Low Costs?

Tenet Healthcare (THC) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Is a Surprise Coming for Tenet Healthcare (THC) This Earnings Season?

DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (NYSE: THC) plans to report results for its first quarter ending March 31, 2022, after the market closes on Wednesday, April 20, 2022. The company will host a related conference call the following morning, Thursday, April 21, 2022, at 10:00 a.m. Eastern time (9:00 a.m. Central time). A live webcast and audio archive of the call may be accessed through the investor relations section of Tenet's website at www.tenethealth.com/investors. About T

News for Tenet Healthcare Stock (THC)